This report is also available at www.activebiotech.comActive Biotech AB Interim report January-March 2009 (Marketwire Finance)
Draths Corp., a biotech startup that’s developed an environmentally friendly process for making nylon fibers and resins, has closed on the first piece of what could grow to a $21.4 million round of venture financing.Maker of ‘green’ nylon raising $21M in VC funds (BizJournals)
One lab’s groundbreaking approach to tailoring drugs that meet only a specific target within the body has focused on anti-inflammatory, anti-AIDS and anti-cancer drugs since 1982. Corticosteroids are powerful drugs used to treat inflammatory conditions such as asthma and other chronic diseases which has made them among the most widely prescribed drugs. Although the anti-inflammatory drugs offer swift relief to the patient, they can carry with them serious side effects. biotech report
Bionovo, Inc. (Nasdaq: BNVI) announced the online publication of a peer-reviewed article in the journal, Menopause, reporting Menerba(TM) (formerly MF101) is well tolerated, safe and effective for the treatment of vasomotor symptoms (hot flashes and night sweats) associated with menopause. The Phase 2 clinical trial was designed to evaluate the safety and efficacy of two doses of Menerba versus placebo. The trial was conducted under the direction of Dr. biotech report
In addition to providing a simple and much less expensive means of making artemisinin, the most powerful anti-malaria drug in use today, synthetic biology can also help to extend the effectiveness of this drug. Fermenting artemisinin via engineered microbes, such as yeast, can be done at far lower costs than extracting the drug from Artemsisia annua, the sweet wormwood tree, making microbial-based artemisinin a much cheaper but equally effective treatment. biotech report
Roche announced that it has signed a definite agreement under which Roche will acquire 100% of innovatis, a privately held company based in Bielefeld, Germany. innovatis is a leading provider of automated cell analysis solutions, especially focussing on cell counting, viability testing, and cell function analysis in research, as well as bioproduction. The purchase price for this transaction is 15 million Euros. biotech report
